Remodeling of T-cell mitochondrial metabolism to treat autoimmune diseases
Open Access
- 29 July 2024
- journal article
- research article
- Published by Elsevier in Autoimmunity Reviews
- Vol. 23 (6) , 103583
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 285 references indexed in Scilit:
- Redox Pathogenesis in Rheumatic DiseasesACR Open Rheumatology, 2024
- Reduction of Proinflammatory Effector Functions Through Remodeling of Fatty Acid Metabolism in CD8+ T Cells From Rheumatoid Arthritis PatientsArthritis & Rheumatology, 2023
- Effect of Tacrolimus vs Intravenous Cyclophosphamide on Complete or Partial Response in Patients With Lupus NephritisJAMA Network Open, 2022
- Tissue‐Resident Memory CD8+ T Cells From Skin Differentiate Psoriatic Arthritis From PsoriasisArthritis & Rheumatology, 2021
- Synovial fluid CD69+CD8+ T cells with tissue‐resident phenotype mediate perforin‐dependent citrullination in rheumatoid arthritisClinical & Translational Immunology, 2020
- Glutaminase 1 Inhibition Reduces Glycolysis and Ameliorates Lupus‐like Disease in MRL/lpr Mice and Experimental Autoimmune EncephalomyelitisArthritis & Rheumatology, 2019
- Teriflunomide induces a tolerogenic bias in blood immune cells of MS patientsAnnals of Clinical and Translational Neurology, 2019
- Mitochondrial Dysfunction in the Liver and Antiphospholipid Antibody Production Precede Disease Onset and Respond to Rapamycin in Lupus‐Prone MiceArthritis & Rheumatology, 2016
- Dysregulated Osteoclastogenesis Is Related to Natural Killer T Cell Dysfunction in Rheumatoid ArthritisArthritis & Rheumatology, 2015
- N‐acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: A randomized, double‐blind, placebo‐controlled trialArthritis & Rheumatism, 2012